Dediol

Dediol may be available in the countries listed below.

Ingredient matches for Dediol

Alfacalcidol

Alfacalcidol is reported as an ingredient of Dediol in the following countries:

• Italy

International Drug Name Search

Gastrointestinal Hemorrhage Medications

Definition of Gastrointestinal Hemorrhage: Excessive discharge of blood/profuse bleeding from the stomach and/or intestines.

Drugs associated with Gastrointestinal Hemorrhage

The following drugs and medications are in some way related to, or used in the treatment of Gastrointestinal Hemorrhage. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

See sub-topics

Topics under Gastrointestinal Hemorrhage

• Upper GI Hemorrhage (16 drugs)

Learn more about Gastrointestinal Hemorrhage

Micromedex Care Notes:

• Gastrointestinal Bleeding
• Rectal Bleeding

Medical Encyclopedia:

• Angiodysplasia of the colon
• Bloody or tarry stools
• Gastrointestinal bleeding
• Vomiting blood

Drug List:

Alternagel

Alu-Cap

Alu-Tab

Amphojel

Berkley-And-Jensen-Acid-Reducer-Maximum-Strength

Careone-Acid-Reducer

Deprizine

Dialume

Equaline-Heartburn-Relief

Pitressin

Sunmark-Acid-Reducer-Maximum-Strength

Taladine

Zantac

Zantac-150

Zantac-150-Efferdose-Effervescent-Tablets

Zantac-25-Mg-Efferdose-Effervescent-Tablets

Zantac-300

Zantac-75

Zantac-Efferdose

Zegerid

Lisinopril Hydrochlorothiazide Merck

Lisinopril Hydrochlorothiazide Merck may be available in the countries listed below.

Ingredient matches for Lisinopril Hydrochlorothiazide Merck

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Lisinopril Hydrochlorothiazide Merck in the following countries:

• Spain

Lisinopril

Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Lisinopril Hydrochlorothiazide Merck in the following countries:

• Spain

International Drug Name Search

Frumil

Frumil may be available in the countries listed below.

UK matches:

• Frumil, Frumil LS (SPC)

Ingredient matches for Frumil

Amiloride

Amiloride hydrochloride dihydrate (a derivative of Amiloride) is reported as an ingredient of Frumil in the following countries:

• Greece


• Ireland


• New Zealand


• United Kingdom

Furosemide

Furosemide is reported as an ingredient of Frumil in the following countries:

• Greece


• Ireland


• New Zealand


• United Kingdom

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Amantadinsulfat Fresenius

Amantadinsulfat Fresenius may be available in the countries listed below.

Ingredient matches for Amantadinsulfat Fresenius

Amantadine

Amantadine sulfate (a derivative of Amantadine) is reported as an ingredient of Amantadinsulfat Fresenius in the following countries:

• Austria

International Drug Name Search

Fluoksetyna

Fluoksetyna may be available in the countries listed below.

Ingredient matches for Fluoksetyna

Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Fluoksetyna in the following countries:

• Poland

International Drug Name Search

Xopenex HFA

See also: Generic Xopenex

Xopenex HFA is a brand name of levalbuterol, approved by the FDA in the following formulation(s):

XOPENEX HFA (levalbuterol tartrate - aerosol, metered; inhalation)

• 
  Manufacturer: SUNOVION
  
  Approval date: March 11, 2005
  
  Strength(s): EQ 0.045MG BASE/INH ^[RLD]

Has a generic version of Xopenex HFA been approved?

No. There is currently no therapeutically equivalent version of Xopenex HFA available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Xopenex HFA. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Method for treating asthma using optically pure (R)-albuterol
  Patent 5,362,755
  Issued: November 8, 1994
  Inventor(s): Barberich; Timothy J. & Young; James W.
  Assignee(s): Sepracor, Inc.
  The optically pure R(-) isomer of albuterol, which is substantially free of the S(+) isomer, is a potent bronchodilator for relieving the symptoms associated with asthma in individuals. A method is disclosed utilizing the optically pure R(-) isomer of albuterol for treating asthma while minimizing the side effects associated with chronic administration of racemic albuterol.
  
  Patent expiration dates:
  
  
  • March 25, 2013
    
    ✓ 
    Patent use: TREATMENT OR PREVENTION OF BRONCHOSPASM OR ASTHMATIC SYMPTOMS
  
  



• 
  Method for treating asthma using optically pure R(-) albuterol
  Patent 5,547,994
  Issued: August 20, 1996
  Inventor(s): Barberich; Timothy J. & Young; James W.
  Assignee(s): Sepracor, Inc.
  The optically pure R(-) isomer of albuterol, which is substantially free of the S(+) isomer, is a potent bronchodilator for relieving the symptoms associated with asthma in individuals. A method is disclosed utilizing the optically pure R(-) isomer of albuterol for treating asthma while minimizing the side effects associated with albuterol.
  
  Patent expiration dates:
  
  
  • August 20, 2013
    
    ✓ 
    Patent use: TREATMENT OR PREVENTION OF BRONCHOSPASM OR ASTHMATIC SYMPTOMS
  
  



• 
  Medicinal aerosol formulations
  Patent 5,605,674
  Issued: February 25, 1997
  Inventor(s): Purewal; Tarlochan S. & Greenleaf; David J.
  Assignee(s): Riker Laboratories, Inc.
  A self-propelling aerosol formulation which may be free from CFC's which comprises a medicament, 1,1,1,2-tetrafluoroethane, a surface active agent and at least one compound having a higher polarity than 1,1,1,2-tetrafluoroethane.
  
  Patent expiration dates:
  
  
  • February 25, 2014
    
    ✓ 
    Drug product
  
  



• 
  Seals for use in an aerosol delivery device
  Patent 5,836,299
  Issued: November 17, 1998
  Inventor(s): Kwon; Oh-Seung
  Assignee(s): Minnesota Mining & Manufacturing Co.
  A device for delivering an aerosol, comprising: a casing member, a valve stem, and a diaphragm. The diaphragm is made of an ethylene-propylene-diene rubber ("EPDM") and is stable to dimensional change when exposed to 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoroethane.
  
  Patent expiration dates:
  
  
  • November 17, 2015
    
    ✓ 
    Drug product
  
  



• 
  Levalbuterol salt
  Patent 7,256,310
  Issued: August 14, 2007
  Inventor(s): McGlynn; Paul & Bakale; Roger & Sturge; Craig
  Assignee(s): Sepracor Inc.
  Levalbuterol L-tartrate affords crystals possessing properties desirable for use in a metered dose inhaler.
  
  Patent expiration dates:
  
  
  • October 8, 2024
    
    ✓ 
    Patent use: TREATMENT OR PREVENTION OF BRONCHOSPASM OR ASTHMATIC SYMPTOMS
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  

See also...

• Xopenex HFA Aerosol Consumer Information (Wolters Kluwer)
• Xopenex HFA Consumer Information (Cerner Multum)
• Xopenex HFA Advanced Consumer Information (Micromedex)
• Levalbuterol Aerosol Consumer Information (Wolters Kluwer)
• Levalbuterol Solution Consumer Information (Wolters Kluwer)
• Levalbuterol Consumer Information (Cerner Multum)
• Xopenex Pediatric Advanced Consumer Information (Micromedex)
• Levalbuterol Inhalation, oral/nebulization Advanced Consumer Information (Micromedex)
• Levalbuterol AHFS DI Monographs (ASHP)

Atmos

Atmos may be available in the countries listed below.

Ingredient matches for Atmos

Testosterone

Testosterone is reported as an ingredient of Atmos in the following countries:

• Iceland

International Drug Name Search